BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8417251)

  • 1. "Benign" monoclonal gammopathy--after 20 to 35 years of follow-up.
    Kyle RA
    Mayo Clin Proc; 1993 Jan; 68(1):26-36. PubMed ID: 8417251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current concepts on monoclonal gammopathies.
    Kyle RA
    Aust N Z J Med; 1992 Jun; 22(3):291-302. PubMed ID: 1497556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Benign' monoclonal gammopathy. A misnomer?
    Kyle RA
    JAMA; 1984 Apr; 251(14):1849-54. PubMed ID: 6422066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic criteria of multiple myeloma.
    Kyle RA
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal gammopathy of undetermined significance.
    Kyle RA
    Blood Rev; 1994 Sep; 8(3):135-41. PubMed ID: 7819815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral neuropathies associated with monoclonal proteins: a clinical review.
    Kelly JJ
    Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA
    Eur J Haematol Suppl; 1989; 51():70-5. PubMed ID: 2516809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of IgM monoclonal gammopathy in 430 cases.
    Kyle RA; Garton JP
    Mayo Clin Proc; 1987 Aug; 62(8):719-31. PubMed ID: 3110508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal gammopathy and multiple myeloma in the elderly.
    Kyle RA
    Baillieres Clin Haematol; 1987 Jun; 1(2):533-57. PubMed ID: 3322448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders.
    Higgins L; Nasr SH; Said SM; Kapoor P; Dingli D; King RL; Rajkumar SV; Kyle RA; Kourelis T; Gertz MA; Dispenzieri A; Lacy MQ; Buadi FK; Ansell SM; Gonsalves WI; Thompson CA; Fervenza FC; Zand L; Hwa YL; Jevremovic D; Shi M; Leung N
    Clin J Am Soc Nephrol; 2018 Jul; 13(7):1037-1046. PubMed ID: 29848505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal gammopathy of undetermined significance (MGUS).
    Kyle RA
    Baillieres Clin Haematol; 1995 Dec; 8(4):761-81. PubMed ID: 8845571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody activity of monoclonal immunoglobulins in myeloma, macroglobulinemia and benign gammapathy.
    Waldenström JG
    Med Oncol Tumor Pharmacother; 1986; 3(3-4):135-40. PubMed ID: 3100882
    [No Abstract]   [Full Text] [Related]  

  • 13. [Subsets of T cells in myeloma, macroglobulinemia and benign monoclonal gammopathy: analysis of surface markers defined by monoclonal antibodies and the effect on Ig-synthesis by B cells].
    Okagawa K; Iguchi K; Iishi Y; Kosaka M
    Nihon Ketsueki Gakkai Zasshi; 1985 Aug; 48(5):1205-13. PubMed ID: 3934898
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
    Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The monoclonal gammopathies.
    Kyle RA
    Clin Chem; 1994 Nov; 40(11 Pt 2):2154-61. PubMed ID: 7955402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients.
    Chauvet S; Bridoux F; Ecotière L; Javaugue V; Sirac C; Arnulf B; Thierry A; Quellard N; Milin S; Bender S; Goujon JM; Jaccard A; Fermand JP; Touchard G
    Am J Kidney Dis; 2015 Nov; 66(5):756-67. PubMed ID: 25987261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential diagnosis of monoclonal gammopathy.
    Gandara DR; Mackenzie MR
    Med Clin North Am; 1988 Sep; 72(5):1155-67. PubMed ID: 3137401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
    J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal gammopathies of undetermined significance.
    Kyle RA; Rajkumar SV
    Rev Clin Exp Hematol; 2002 Sep; 6(3):225-52. PubMed ID: 12616697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
    Kyle RA; Dispenzieri A; Kumar S; Larson D; Therneau T; Rajkumar SV
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):74-6. PubMed ID: 21454195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.